Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-03-14T11:37:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now lists revision v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T04:59:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Added sponsor/institution references and a 'Helpful Links Provided by' section in the page footer (Moffitt Cancer Center Clinical Trials website, H. Lee Moffitt Cancer Center and Research Institute).
    Difference
    0.1%
    Check dated 2026-02-28T00:44:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Removed sponsor/affiliation blocks for Moffitt Cancer Center and the associated 'Helpful Links' section.
    Difference
    0.1%
    Check dated 2026-02-20T20:49:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:36:34.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.0 to v3.4.1, likely a template/UI adjustment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T00:02:25.000Z thumbnail image

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.